Anti-Bacillus Anthracis Protective Antigen Recombinant Antibody(Raxibacumab)

Product Information

Catalog Number	YR1171
Product Name	Anti-Bacillus Anthracis Protective Antigen Recombinant Antibody(Raxibacumab)
Molecular Name	Raxibacumab
Alias	Anti-Protective Antigen Recombinant Antibody, Research Grade Raxibacumab
CAS Number	565451-13-0
Molecular Weight	142.84 kDa
Target	Anthrax protective antigen[Bacillus anthracis]
Isotype	IgG1 Lambda
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys. In December 2012 raxibacumab was approved in the United States for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price